Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Abraham

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|December 1, 1991
Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin betaC E Halstenson, M Macres, S A Katz, et al.
Journal of Clinical Pharmacology|April 1, 1992
The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal functionC E Halstenson, J A Opsahl, K Rachael, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1991
Analysis of active renin heterogeneityS A Katz, R L Malvin, J Lee, et al.
Journal of Clinical Pharmacology|February 1, 1989
Disposition of guanadrel in subjects with normal and impaired renal functionC E Halstenson, J A Opsahl, P A Abraham, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
The disposition and dynamics of labetalol in patients on dialysisC E Halstenson, J A Opsahl, T V Pence, et al.
Clinical Pharmacology and Therapeutics|January 1, 1988
Pharmacokinetics and pharmacodynamics of codeine in end-stage renal diseaseD R Guay, W M Awni, J W Findlay, et al.
Journal of Clinical Pharmacology|December 1, 1987
Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteersD R Guay, W M Awni, C E Halstenson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1991
The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter studyM Moser, P A Abraham, W M Bennett, et al.
Clinical Pharmacology and Therapeutics|August 1, 1992
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomiesP A Abraham, C E Halstenson, M M Macres, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1990
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietinP A Abraham, J A Opsahl, P R Keshaviah, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|December 1, 1991
Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin betaC E Halstenson, M Macres, S A Katz, et al.
Journal of Clinical Pharmacology|April 1, 1992
The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal functionC E Halstenson, J A Opsahl, K Rachael, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1991
Analysis of active renin heterogeneityS A Katz, R L Malvin, J Lee, et al.
Journal of Clinical Pharmacology|February 1, 1989
Disposition of guanadrel in subjects with normal and impaired renal functionC E Halstenson, J A Opsahl, P A Abraham, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
The disposition and dynamics of labetalol in patients on dialysisC E Halstenson, J A Opsahl, T V Pence, et al.
Clinical Pharmacology and Therapeutics|January 1, 1988
Pharmacokinetics and pharmacodynamics of codeine in end-stage renal diseaseD R Guay, W M Awni, J W Findlay, et al.
Journal of Clinical Pharmacology|December 1, 1987
Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteersD R Guay, W M Awni, C E Halstenson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1991
The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter studyM Moser, P A Abraham, W M Bennett, et al.
Clinical Pharmacology and Therapeutics|August 1, 1992
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomiesP A Abraham, C E Halstenson, M M Macres, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1990
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietinP A Abraham, J A Opsahl, P R Keshaviah, et al.
Pageof 7